Actively Recruiting
Optimized MRI of Patients With Hip Arthroplasty
Led by NYU Langone Health · Updated on 2026-03-04
22
Participants Needed
1
Research Sites
281 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
R
Radiological Society of North America
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.
CONDITIONS
Official Title
Optimized MRI of Patients With Hip Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
- Referred for MRI examination at the discretion of the treating physician
- Provision of signed and dated informed consent form
- No metal hardware in the body including contralateral hip arthroplasty
- No contraindication to MRI: defined as claustrophobia or presence of other MRI-incompatible devices
You will not qualify if you...
- History of revision hip arthroplasty
- Pregnancy (self-reported, or self-suspected)
- Hip arthroplasty surgery within one year of enrollment
- Clinical indication to administer intravenous contrast material during MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Radiology - Center for Biomedical Imaging
New York, New York, United States, 10017
Actively Recruiting
Research Team
I
Iman Khodarahmi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here